Promega Corporation

ApoLive-Glo™ Multiplex Assay Technical Manual

Literature # TM325

The ApoLive-Glo™ Multiplex Assay combines two assay chemistries to assess viability and caspase activation events within a single assay well. The first part of the assay measures the activity of a protease marker of cell viability. The live-cell protease activity is restricted to intact viable cells and is measured using a fluorogenic, cell-permeant, peptide substrate (glycyl-phenylalanyl-amino fluorocoumarin; GF-AFC). The substrate enters intact cells, where it is cleaved by the live-cell protease activity to generate a fluorescent signal proportional to the number of living cells (Figure 1). This live-cell protease becomes inactive upon loss of cell membrane integrity and leakage into the surrounding culture medium. The second part of the assay uses the Caspase-Glo™ Assay technology to detect caspase-3/7 activation, which is a key biomarker of apoptosis. The assay allows you to measure viability and apoptosis in the same sample well.

Printed in USA. Revised 12/12.

PDF Icon Complete Protocol PDF (1017kb)

PDF Icon Quick Protocol PDF (49kb)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »